Wellster HealthTech Secures EUR10M Debt for Global Expansion

Wellster HealthTech, a prominent German digital health innovator, has significantly bolstered its financial capacity by extending its credit line with Claret Capital Partners to EUR10 million. This strategic move is designed to fuel the company's ambitious international expansion plans, marking a new phase of growth for the direct-to-consumer health solutions provider.

The expanded debt facility underscores the strong confidence held by Claret Capital Partners, a UK-based growth debt specialist, in Wellster HealthTech's established operational model and its demonstrated capacity for scaling. This partnership, which has seen Claret Capital Partners provide ongoing financial support, is now positioned to enable substantial geographic diversification for the company's suite of digital health brands.

Founded in 2018, Wellster HealthTech has carved out a niche by offering accessible online medical treatments through its portfolio of brands, including easytest, GoEasy, GoLighter, mySummer, mySpring, and Spring. The company reported a robust performance in the 2025 financial year, achieving EUR50 million in revenue and reaching full profitability for the first time. This financial milestone was previously supported by investments from entities including Claret Capital Partners and Mangrove Capital, which collectively contributed $20 million.

The immediate focus of this enhanced funding is the launch of Wellster HealthTech's international strategy, commencing with its entry into the Swedish market. The GoLighter obesity therapy platform will be the initial offering in Sweden, serving as a critical pilot market to refine strategies before a wider European rollout. This phased approach aims to mitigate risks and optimize market penetration across diverse European healthcare systems.

The digital health sector continues to experience dynamic growth, driven by increasing consumer demand for convenient and personalized healthcare solutions. With an estimated global market size projected to reach hundreds of billions of dollars in the coming years, companies like Wellster HealthTech are well-positioned to capitalize on this trend. The company's focus on direct-to-consumer models and effective online treatment delivery aligns perfectly with evolving patient expectations and technological advancements in telehealth.

This expansion of debt financing by Claret Capital Partners highlights a growing trend of specialized debt providers supporting high-growth technology companies in the European market. Such facilities offer crucial capital without the immediate dilution associated with equity rounds, allowing founders to maintain ownership while aggressively pursuing growth objectives. The success of Wellster HealthTech in achieving profitability further solidifies its attractiveness to growth-focused lenders.

Looking ahead, Wellster HealthTech's international foray, starting with Sweden, is expected to pave the way for further market entries across the continent. The company's ability to leverage its existing profitable business model and its established relationships with financial partners like Claret Capital Partners and Mangrove Capital provides a strong foundation for sustained global expansion and market leadership in the digital therapeutics space.